Promis Neurosciences Inc

Biotech Stocks Healthcare Stocks

$13.49

+0.79 (+6.22%)

As of Apr 1, 3:56 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +70.5% upside

Low Target $15.62

Average Target $23.00

High Target $28.09

Current Price $13.49

Current
$13.49

Target
$23.00

$15.62 $23.00 avg $28.09

Scenario Analysis

Bear Case

$15.62

15.8%

Low target

Base Case

$23.00

+70.5%

Avg target

Bull Case

$28.09

+108.2%

High target

Risk/Reward

6.9x

Highly favorable

Price in Context

52-Week High

$39.75

-66.1% from high

52-Week Low

$6.27

+115.2% from low

Target vs 52W High

$23.00

-42.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%